TrialPath
Recruiting

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

NCT07388524 · National Cancer Institute (NCI)
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Evaluating Adjuvant Atezolizumab or Atezolizumab and Hyaluronidase-TQJS to Prevent Recurrence in Stage I Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase III Trial (AASI-NSCLC)
About this study
PRIMARY OBJECTIVE: I. To compare disease-free survival (DFS) in the intent-to-treat patient population, among patients randomized to receive atezolizumab for one year (Arm B) versus (vs.) observation (Arm A). SECONDARY OBJECTIVES: I. To compare overall survival (OS) between patients randomized to atezolizumab versus observation. II. To compare recurrence-free survival (RFS) between patients randomized to atezolizumab versus observation. III. To compare lung-cancer-specific OS between patients randomized to atezolizumab versus observation. IV. To compare rates of loco-regional recurrences between patients randomized to atezolizumab versus observation. V. To compare rates of distant recurrences between patients randomized to atezolizumab versus observation. VI. To compare adverse event rates (AEs) via Common Terminology Criteria for Adverse Events (CTCAE) version (v) 5 between patients randomized to atezolizumab versus observation. OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients undergo observation for 1 year. Patients also undergo computed tomography (CT) and optional collection of blood samples throughout the trial. ARM B: Patients receive atezolizumab intravenously (IV) over 60 minutes or atezolizumab and recombinant human hyaluronidase subcutaneously (SC) over 7 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 1 year (17 cycles) in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and optional collection of blood samples throughout the trial. After completion of study treatment, patients are followed up at 30 days (patients in Arm B only), then every 6 months for 3 years and then annually thereafter for an additional 7 years (10 years total).
Eligibility criteria
Inclusion Criteria: * Pathologically stage IA3 or IB NSCLC per American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 9th edition * Note: Tumors with any histology are allowed including both squamous and non-squamous subtypes, except those containing small-cell morphology. Non-squamous histology includes adenocarcinoma, large cell neuroendocrine, poorly differentiated tumors and adenosquamous, etc * Patient must have undergone complete surgical resection with negative margins (complete R0 resection). Surgical resection must be lobectomy or higher, unless the tumor measured no more than 2 cm based on clinical staging, where sub-lobar resection, e.g., wedge or segmentectomy, will be acceptable * Note: For patients who underwent sub-lobar resection for clinical tumors size of ≤ 2.0 cm, must have CT chest confirming tumor size within 60 days of surgical resection. Patients who received a lobectomy or higher do not require to fulfill this imaging criteria * Patient must have undergone adequate nodal sampling as defined by Commission on Cancer, 2020 Standard. Adequate nodal sampling includes pathological evaluation of at least one (named and/or numbered) hilar station (level 10 or higher) and at least three distinct (named and or numbered) mediastinal stations (level 2-9) * PD-L1 immunohistochemistry showing tumor proportion score (TPS) ≥ 50%, by an Food and Drug Administration (FDA)-approved assay including but not limited to SP263, SP142, 22C3, 28-8, performed either on surgical specimen or biopsy specimen * No EGFR exon 19 deletion (del) or L858R mutation or ALK fusion; molecular testing may have been performed either on surgical specimen or biopsy specimen. Tumors with purely squamous histology are not required to undergo EGFR or ALK gene testing * Patient to be registered to A082302 no earlier than 21 days and no later than 77 days from surgical resection * Recovered from surgical resection as determined by the treating provider or the investigator * No prior neoadjuvant or adjuvant therapy for current lung cancer diagnosis * Patient must NOT have uncontrolled intercurrent illness, including but not limited to serious ongoing or active infection, symptomatic congestive heart failure (New York Heart Association \[NYHA\] class ≥ III), unstable angina, or unstable arrhythmia * No current pneumonitis or history of (non-infectious) pneumonitis that required steroids or history of interstitial lung disease (ILD) * No active auto-immune disease that has required systemic treatment within the last 2 years (e.g., disease modifying agents, corticosteroids, or immunomodulatory agents). Replacement therapy (e.g., thyroid for history of autoimmune thyroiditis, insulin for type I or II diabetes, corticosteroids for adrenal or pituitary insufficiency) is not considered a form of systemic treatment * No known hypersensitivity (≥ grade 3) to atezolizumab and/or any of its excipients * No live vaccine within 30 days prior to registration. Examples include but are not limited to: measles, mumps, rubella, varicella, yellow fever, Bacillus Calmette-Guerin (BCG), typhoid, nasally administered influenza * No history of prior allogeneic bone marrow, stem cell, or solid organ transplant * Patient has not received continuous systemic treatment with corticosteroids (\> 10 mg daily prednisone or equivalents) or other immunosuppressive medications within 14 days prior to registration, with the following exceptions: * Inhaled or topical steroids and adrenal replacement doses ≤ 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease. Patients are permitted to use topical, ocular, intra-articular, intranasal, and inhalational corticosteroids (with minimal systemic absorption). Physiologic replacement doses of systemic corticosteroids are permitted, if \< 10 mg/day prednisone equivalents. A brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen or chronic obstructive pulmonary disease \[COPD\] exacerbation) is permitted * Age ≥ 18 years * Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 (or Karnofsky ≥ 60%) * Absolute neutrophil count (ANC) ≥ 1,500/mm\^3 * Platelet count ≥ 100,000/mm\^3 * Total bilirubin ≤ 1.5 x upper limit of normal (ULN), except patients with Gilbert syndrome who can have total bilirubin \< 3.0 mg/dl * Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase \[SGOT\])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase \[SGPT\]) ≤ 3 x upper limit of normal (ULN) * Creatinine clearance ≥ 30 mL/min (using standard Cockcroft-Gault formula, unless measured creatinine clearance \[CrCl\] is available and meet the specified threshold) * Not pregnant and not nursing, because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects * Therefore, for women of childbearing potential only, a negative urine or serum pregnancy test done ≤ 7 days prior to registration is required * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * HIV: Patients with known HIV infection on effective anti-retroviral therapy with undetectable viral load within 6 months prior to registration are eligible for this trial. Patients with no known history of HIV do not require any testing * Hepatitis B and hepatitis C: No active hepatitis B (defined as negative for hepatitis B \[HepB\] deoxyribonucleic acid \[DNA\], and positive for HepB surface antibody) or hepatitis C (defined as hepatitis C virus \[HCV\] ribonucleic acid \[RNA\] \[qualitative\] detected) infection. If there is a history of either infection, patient should be negative for active disease, for hepatitis B negative for hepatitis B virus surface antigen (HBsAg), and for hepatitis C - negative for HCV RNA (qualitative). Patients with no known history of chronic hepatitis do not require any testing * No active infection requiring systemic therapy * Cardiac function: Patients with known history or current symptoms of heart failure, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association functional classification. To be eligible for this trial, patients should be class 2B or better
Study design
Enrollment target: 336 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2027-03-02
Estimated completion: 2032-09-30
Last updated: 2026-11-20
Interventions
Biological: AtezolizumabBiological: Atezolizumab and Recombinant Human HyaluronidaseProcedure: Biospecimen CollectionProcedure: Computed TomographyOther: Patient Observation
Primary outcomes
  • • Disease-free survival (From randomization to disease recurrence, second lung primary, or death, assessed up to 10 years)
Sponsor
National Cancer Institute (NCI) · nih
Contacts & investigators
InvestigatorMuhammad Furqan · principal_investigator, Alliance for Clinical Trials in Oncology
All locations (171)
Kaiser Permanente-AnaheimRecruiting
Anaheim, California, United States
Kaiser Permanente-Baldwin ParkRecruiting
Baldwin Park, California, United States
Kaiser Permanente-BellflowerRecruiting
Bellflower, California, United States
Tower Cancer Research FoundationRecruiting
Beverly Hills, California, United States
Kaiser Permanente-FontanaRecruiting
Fontana, California, United States
Kaiser Permanente South BayRecruiting
Harbor City, California, United States
Kaiser Permanente-IrvineRecruiting
Irvine, California, United States
Kaiser Permanente Los Angeles Medical CenterRecruiting
Los Angeles, California, United States
Kaiser Permanente West Los AngelesRecruiting
Los Angeles, California, United States
Cedars-Sinai Medical CenterRecruiting
Los Angeles, California, United States
Kaiser Permanente-OntarioRecruiting
Ontario, California, United States
Kaiser Permanente - Panorama CityRecruiting
Panorama City, California, United States
Kaiser Permanente-RiversideRecruiting
Riverside, California, United States
Kaiser Permanente-San Diego ZionRecruiting
San Diego, California, United States
Kaiser Permanente-San MarcosRecruiting
San Marcos, California, United States
Cedars-Sinai Cancer - TarzanaRecruiting
Tarzana, California, United States
Torrance Memorial Physician Network - Cancer CareRecruiting
Torrance, California, United States
Kaiser Permanente-Woodland HillsRecruiting
Woodland Hills, California, United States
Beebe South Coastal Health CampusRecruiting
Millville, Delaware, United States
Helen F Graham Cancer CenterRecruiting
Newark, Delaware, United States
Medical Oncology Hematology Consultants PARecruiting
Newark, Delaware, United States
Beebe Health CampusRecruiting
Rehoboth Beach, Delaware, United States
Kootenai Health - Coeur d'AleneRecruiting
Coeur d'Alene, Idaho, United States
Kootenai Clinic Cancer Services - Post FallsRecruiting
Post Falls, Idaho, United States
Kootenai Clinic Cancer Services - SandpointRecruiting
Sandpoint, Idaho, United States
Illinois CancerCare-BloomingtonRecruiting
Bloomington, Illinois, United States
Illinois CancerCare-CantonRecruiting
Canton, Illinois, United States
Illinois CancerCare-CarthageRecruiting
Carthage, Illinois, United States
John H Stroger Jr Hospital of Cook CountyRecruiting
Chicago, Illinois, United States
Carle at The RiverfrontRecruiting
Danville, Illinois, United States
Cancer Care Specialists of Illinois - DecaturRecruiting
Decatur, Illinois, United States
Decatur Memorial HospitalRecruiting
Decatur, Illinois, United States
Carle Physician Group-EffinghamRecruiting
Effingham, Illinois, United States
Illinois CancerCare-EurekaRecruiting
Eureka, Illinois, United States
Illinois CancerCare-GalesburgRecruiting
Galesburg, Illinois, United States
Illinois CancerCare-Kewanee ClinicRecruiting
Kewanee, Illinois, United States
Illinois CancerCare-MacombRecruiting
Macomb, Illinois, United States
Carle Physician Group-Mattoon/CharlestonRecruiting
Mattoon, Illinois, United States
Carle BroMenn Medical CenterRecruiting
Normal, Illinois, United States
Carle Cancer Institute NormalRecruiting
Normal, Illinois, United States
Cancer Care Center of O'FallonRecruiting
O'Fallon, Illinois, United States
HSHS Saint Elizabeth's HospitalRecruiting
O'Fallon, Illinois, United States
Illinois CancerCare-Ottawa ClinicRecruiting
Ottawa, Illinois, United States
Illinois CancerCare-PekinRecruiting
Pekin, Illinois, United States
Illinois CancerCare-PeoriaRecruiting
Peoria, Illinois, United States
Illinois CancerCare-PeruRecruiting
Peru, Illinois, United States
Illinois CancerCare-PrincetonRecruiting
Princeton, Illinois, United States
Southern Illinois University School of MedicineRecruiting
Springfield, Illinois, United States
Springfield ClinicRecruiting
Springfield, Illinois, United States
Springfield Memorial HospitalRecruiting
Springfield, Illinois, United States
Carle Cancer CenterRecruiting
Urbana, Illinois, United States
Illinois CancerCare - WashingtonRecruiting
Washington, Illinois, United States
Northwest Cancer Center - Crown PointRecruiting
Crown Point, Indiana, United States
Northwest Oncology LLCRecruiting
Dyer, Indiana, United States
Saint Mary Medical CenterRecruiting
Hobart, Indiana, United States
Saint Catherine HospitalRecruiting
Indianapolis, Indiana, United States
The Community HospitalRecruiting
Munster, Indiana, United States
Women's Diagnostic Center - MunsterRecruiting
Munster, Indiana, United States
Northwest Cancer Center - ValparaisoRecruiting
Valparaiso, Indiana, United States
Mary Greeley Medical CenterRecruiting
Ames, Iowa, United States
McFarland Clinic - AmesRecruiting
Ames, Iowa, United States
Physicians' Clinic of Iowa PCRecruiting
Cedar Rapids, Iowa, United States
Mercy HospitalRecruiting
Cedar Rapids, Iowa, United States
Oncology Associates at Mercy Medical CenterRecruiting
Cedar Rapids, Iowa, United States
McFarland Clinic - Trinity Cancer CenterRecruiting
Fort Dodge, Iowa, United States
McFarland Clinic - MarshalltownRecruiting
Marshalltown, Iowa, United States
University of Kansas Clinical Research CenterRecruiting
Fairway, Kansas, United States
University of Kansas Cancer CenterRecruiting
Kansas City, Kansas, United States
The University of Kansas Cancer Center - OlatheRecruiting
Olathe, Kansas, United States
University of Kansas Cancer Center-Overland ParkRecruiting
Overland Park, Kansas, United States
University of Kansas Hospital-Indian Creek CampusRecruiting
Overland Park, Kansas, United States
University of Kansas Hospital-Westwood Cancer CenterRecruiting
Westwood, Kansas, United States
University of Kentucky/Markey Cancer CenterRecruiting
Lexington, Kentucky, United States
Owensboro Health Mitchell Memorial Cancer CenterRecruiting
Owensboro, Kentucky, United States
Bronson Battle CreekRecruiting
Battle Creek, Michigan, United States
Corewell Health Grand Rapids Hospitals - Butterworth HospitalRecruiting
Grand Rapids, Michigan, United States
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalRecruiting
Grand Rapids, Michigan, United States
Bronson Methodist HospitalRecruiting
Kalamazoo, Michigan, United States
West Michigan Cancer CenterRecruiting
Kalamazoo, Michigan, United States
Corewell Health Lakeland Hospitals - Niles HospitalRecruiting
Niles, Michigan, United States
Corewell Health Reed City HospitalRecruiting
Reed City, Michigan, United States
Corewell Health Lakeland Hospitals - Marie Yeager Cancer CenterRecruiting
Saint Joseph, Michigan, United States
Corewell Health Lakeland Hospitals - Saint Joseph HospitalRecruiting
Saint Joseph, Michigan, United States
Munson Medical CenterRecruiting
Traverse City, Michigan, United States
University of Michigan Health - WestRecruiting
Wyoming, Michigan, United States
Sanford Joe Lueken Cancer CenterRecruiting
Bemidji, Minnesota, United States
Essentia Health Saint Joseph's Medical CenterRecruiting
Brainerd, Minnesota, United States
Mercy HospitalRecruiting
Coon Rapids, Minnesota, United States
Essentia Health - Deer River ClinicRecruiting
Deer River, Minnesota, United States
Essentia Health Saint Mary's - Detroit Lakes ClinicRecruiting
Detroit Lakes, Minnesota, United States
Essentia Health Cancer CenterRecruiting
Duluth, Minnesota, United States
Fairview Southdale HospitalRecruiting
Edina, Minnesota, United States
Minnesota Oncology - EdinaRecruiting
Edina, Minnesota, United States
Essentia Health Hibbing ClinicRecruiting
Hibbing, Minnesota, United States
Abbott-Northwestern HospitalRecruiting
Minneapolis, Minnesota, United States
Park Nicollet Clinic - Saint Louis ParkRecruiting
Saint Louis Park, Minnesota, United States
Regions HospitalRecruiting
Saint Paul, Minnesota, United States
United HospitalRecruiting
Saint Paul, Minnesota, United States
Essentia Health SandstoneRecruiting
Sandstone, Minnesota, United States
Essentia Health Virginia ClinicRecruiting
Virginia, Minnesota, United States
Saint Francis Medical CenterRecruiting
Cape Girardeau, Missouri, United States
University of Kansas Cancer Center - BriarcliffRecruiting
Kansas City, Missouri, United States
University of Kansas Cancer Center - NorthRecruiting
Kansas City, Missouri, United States
University of Kansas Cancer Center - Lee's SummitRecruiting
Lee's Summit, Missouri, United States
Liberty HospitalRecruiting
Liberty, Missouri, United States
Community Hospital of AnacondaRecruiting
Anaconda, Montana, United States
Billings Clinic Cancer CenterRecruiting
Billings, Montana, United States
Bozeman Health Deaconess HospitalRecruiting
Bozeman, Montana, United States
Benefis Sletten Cancer InstituteRecruiting
Great Falls, Montana, United States
Logan Health Medical CenterRecruiting
Kalispell, Montana, United States
Community Medical CenterRecruiting
Missoula, Montana, United States
Ocean University Medical CenterRecruiting
Brick, New Jersey, United States
Southern Ocean County Medical CenterRecruiting
Manahawkin, New Jersey, United States
Jersey Shore Medical CenterRecruiting
Neptune City, New Jersey, United States
Riverview Medical Center/Booker Cancer CenterRecruiting
Red Bank, New Jersey, United States
Northwell Health Imbert Cancer CenterRecruiting
Bay Shore, New York, United States
Roswell Park Cancer InstituteRecruiting
Buffalo, New York, United States
Hematology Oncology Associates of CNY at CamillusRecruiting
Camillus, New York, United States
Hematology Oncology Associates of Central New York-East SyracuseRecruiting
East Syracuse, New York, United States
Northwell Health Cancer Institute at HuntingtonRecruiting
Greenlawn, New York, United States
Northwell Health/Center for Advanced MedicineRecruiting
Lake Success, New York, United States
Northern Westchester HospitalRecruiting
Mount Kisco, New York, United States
Manhattan Eye Ear and Throat HospitalRecruiting
New York, New York, United States
Lenox Hill HospitalRecruiting
New York, New York, United States
Queens Cancer CenterRecruiting
Rego Park, New York, United States
Phelps Memorial Hospital CenterRecruiting
Sleepy Hollow, New York, United States
Stony Brook University Medical CenterRecruiting
Stony Brook, New York, United States
Atrium Health Stanly/LCI-AlbemarleRecruiting
Albemarle, North Carolina, United States
Carolinas Medical Center/Levine Cancer InstituteRecruiting
Charlotte, North Carolina, United States
Atrium Health Pineville/LCI-PinevilleRecruiting
Charlotte, North Carolina, United States
Levine Cancer Institute-SouthParkRecruiting
Charlotte, North Carolina, United States
Atrium Health University City/LCI-UniversityRecruiting
Charlotte, North Carolina, United States
Levine Cancer Institute-BallantyneRecruiting
Charlotte, North Carolina, United States
Wake Forest University at ClemmonsRecruiting
Clemmons, North Carolina, United States
Atrium Health Cabarrus/LCI-ConcordRecruiting
Concord, North Carolina, United States
Duke University Medical CenterRecruiting
Durham, North Carolina, United States
Wake Forest University at ElkinRecruiting
Elkin, North Carolina, United States
Levine Cancer Institute - RutherfordRecruiting
Forest City, North Carolina, United States
Levine Cancer Institute-GastonRecruiting
Gastonia, North Carolina, United States
Hayworth Cancer CenterRecruiting
High Point, North Carolina, United States
Atrium Health Lincoln/LCI-LincolntonRecruiting
Lincolnton, North Carolina, United States
Atrium Health Union/LCI-UnionRecruiting
Monroe, North Carolina, United States
FirstHealth of the Carolinas-Moore Regional HospitalRecruiting
Pinehurst, North Carolina, United States
Duke Cancer Center RaleighRecruiting
Raleigh, North Carolina, United States
Atrium Health Cleveland/LCI-ClevelandRecruiting
Shelby, North Carolina, United States
Wake Forest Baptist Health - Hematology Oncology - StatesvilleRecruiting
Statesville, North Carolina, United States
Wake Forest University Health SciencesRecruiting
Winston-Salem, North Carolina, United States
Sanford Bismarck Medical CenterRecruiting
Bismarck, North Dakota, United States
Essentia Health Cancer Center-South University ClinicRecruiting
Fargo, North Dakota, United States
Sanford Broadway Medical CenterRecruiting
Fargo, North Dakota, United States
Sanford Roger Maris Cancer CenterRecruiting
Fargo, North Dakota, United States
ProMedica Flower HospitalRecruiting
Sylvania, Ohio, United States
University of Oklahoma Health Sciences CenterRecruiting
Oklahoma City, Oklahoma, United States
Levine Cancer Institute-Rock HillRecruiting
Rock Hill, South Carolina, United States
Sanford Cancer Center Oncology ClinicRecruiting
Sioux Falls, South Dakota, United States
Sanford USD Medical Center - Sioux FallsRecruiting
Sioux Falls, South Dakota, United States
Swedish Cancer Institute-EdmondsRecruiting
Edmonds, Washington, United States
Swedish Cancer Institute-IssaquahRecruiting
Issaquah, Washington, United States
Swedish Medical Center-First HillRecruiting
Seattle, Washington, United States
Duluth Clinic AshlandRecruiting
Ashland, Wisconsin, United States
Bellin Memorial HospitalRecruiting
Green Bay, Wisconsin, United States
Froedtert Menomonee Falls HospitalRecruiting
Menomonee Falls, Wisconsin, United States
Medical College of WisconsinRecruiting
Milwaukee, Wisconsin, United States
ProHealth D N Greenwald CenterRecruiting
Mukwonago, Wisconsin, United States
Froedtert and MCW Moorland Reserve Health CenterRecruiting
New Berlin, Wisconsin, United States
Drexel Town Square Health CenterRecruiting
Oak Creek, Wisconsin, United States
ProHealth Oconomowoc Memorial HospitalRecruiting
Oconomowoc, Wisconsin, United States
Essentia Health Saint Mary's Hospital - SuperiorRecruiting
Superior, Wisconsin, United States
ProHealth Waukesha Memorial HospitalRecruiting
Waukesha, Wisconsin, United States
UW Cancer Center at ProHealth CareRecruiting
Waukesha, Wisconsin, United States
Froedtert West Bend Hospital/Kraemer Cancer CenterRecruiting
West Bend, Wisconsin, United States